Orchid Chem receives EU approval for bacterial injection

News Flash

Incentives for projects larger than Rs.1000cr: Guj Govt
BSE Bankex up 3.5%, BSE Metal up 5.5%
CNX Midcap Index & Smallcap Index up over 1% each
Sensex closes up 317 pts; Nifty up 74 pts
Govt to tackle proposed oil officers' strike from Jan 7
Contempt of court action to be against striking officers
Strike will hit operations of aviation sector the most
Oil PSU chiefs ask officers to not to strike work
To vote: Log onto www.ndtvprofit.com for details
Vote for CNB Viewers' Choice Car of the Year
Vote for CNB Viewers' Choice Bike of the Year
Kampani has informed the AP police he is not involved
Police personnel from H'bad visited JM Fin on 29 Dec
Sr police officer from H'bad has spoken to Kampani
Kampani currently in Dubai, to return when meeting is over
Rupee closes at 48.54/$ vs 48.57/$ on Friday
No scaling back in product development investments
Reduction in lending rates to increase liquidity flow
Govt trying to balance public welfare & corporate growth
More than 30,000 vehicles need replacement urgently
Welcomes govt's sectoral view to help CV segment
Cutting Lifebuoy soap prices by 7-8%: NW
GTL to consider buyback of equity shares on Jan 15
Expect increased investor appetite for corporate bonds
India and China to maintain the overall GDP growth rate
Markets have priced in the earnings de-growth for Q3
Expect further contraction in interest rates
International trade credit has dried up in last 2-3 weeks
Gujarat Govt announces new Industrial Policy
Incentives for projects larger than Rs 1000cr: Guj Govt

Updated: 04/08/2008 | 06:34 PM IST

Top Stories

Press Trust of India

Monday, August 04, 2008 (Mumbai)

Blog

Comments:

Read (0)

Post

Rate the story

Orchid Chemicals and Pharmaceuticals on Monday said it has received European Union regulatory approval for marketing Piperacillin and Tazobactam injection, used in the treatment of bacterial infection.

The Chennai-based generic pharma firm filed the marketing authorisation for this product with the UK Medicines and Healthcare products Regulatory Agency to enable the company to launch the product across EU countries, Orchid Chemicals said in a filing to Bombay Stock Exchange.

Piperacillin and Tazobactam for injection is used in the treatment or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria.

"Through this approval, we are expanding into a new product range of premium Penicillin Injectables and also foraying into EU generic market," Orchid Chemicals and Pharmaceuticals Managing Director K Raghavendra Rao said.

The company is launching the injection in the European Union through its exclusive marketing alliance with Hospira, Rao added.

Shares of the company closed at Rs 259.60, up 3.67 per cent on the BSE on Monday.